American International Group, Inc. Orgenesis Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.19 - $5.88 $46,018 - $64,580	-10,983 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$4.77 - $8.08 $133 - $226	28 Added 0.26%	10,983 $63,000
Q4 2020 Feb 12, 2021	BUY	$4.4 - $5.63 $655 - $838	149 Added 1.38%	10,955 $49,000
Q3 2020 Nov 04, 2020	SELL	$4.75 - $5.99 $1,163 - $1,467	-245 Reduced 2.22%	10,806 $55,000
Q2 2020 Aug 12, 2020	BUY	$3.6 - $7.84 $39,783 - $86,639	11,051 New	11,051 $67,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $43.2M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.